CLEERLY
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
CLEERLY
Industry:
Apps Artificial Intelligence Health Care Medical Wellness
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.cleerlyhealth.com
Total Employee:
101+
Status:
Active
Contact:
917-238-0569
Total Funding:
280.48 M USD
Technology used in webpage:
Google Font API Google Analytics Nginx Amazon AJAX Libraries API PHP PHP 7 Amazon Virginia Region Google Analytics Classic FreePrivacyPolicy.com
Similar Organizations
Concert Health
Concert Health focuses on building an integrated behavioral health system.
Hazel Health
Hazel Health is a healthcare company that improves the health and well-being of students by increasing access to healthcare.
Lemonaid Health
Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
mfine
Mfine is a health-tech startup developing an AI-powered telemedicine mobile app.
OncoHealth
OncoHealth is the leading digital health company focused on navigating the physical, mental and financial complexities of cancer care,
Pathway Medical
Empowering clinicians and healthcare organizations to provide better, more efficient care.
Syllable
Syllable uses AI to transform the way healthcare systems initiate and cultivate relationships with patients.
Current Advisors List
Board_member
Board_member
Board_member
Board_observer
2021-02-01
Current Employees Featured
James P Earls Chief Medical Officer @ Cleerly
Chief Medical Officer
2018-02-01
Kimberly McCombs Chief Strategy Officer @ Cleerly
Chief Strategy Officer
2020-06-01
Brandon Atkinson Chief Operating Officer @ Cleerly
Chief Operating Officer
2021-07-01
James K. Min Founder and Chief Executive Officer @ Cleerly
Founder and Chief Executive Officer
2019-10-01
Nick Nieslanik Chief Technology Officer @ Cleerly
Chief Technology Officer
2021-06-01
Jim Hartman Chief Revenue Officer @ Cleerly
Chief Revenue Officer
2021-10-01
Founder
Investors List
LRVHealth
LRVHealth investment in Series C - Cleerly
Cigna Ventures
Cigna Ventures investment in Series C - Cleerly
Vensana Capital
Vensana Capital investment in Series C - Cleerly
DigiTx Partners
DigiTx Partners investment in Series C - Cleerly
T. Rowe Price
T. Rowe Price investment in Series C - Cleerly
Peter Thiel
Peter Thiel investment in Series C - Cleerly
Novartis
Novartis investment in Series C - Cleerly
Presight Capital
Presight Capital investment in Series C - Cleerly
Mirae Asset Capital
Mirae Asset Capital investment in Series C - Cleerly
New Leaf Ventures
New Leaf Ventures investment in Series C - Cleerly
Official Site Inspections
http://www.cleerlyhealth.com Semrush global rank: 1.32 M Semrush visits lastest month: 22.09 K
- Host name: 199.60.103.133
- IP address: 199.60.103.133
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Cleerly"
Personalized Analysis and Treatment of Heart Disease | Cleerly
1 Omori, Hiroyuki, et al. Determination of lipid-rich plaques by artificial intelligence-enabled quantitative computed tomography using near-infrared spectroscopy as reference. …See details»
Contact Us | Cleerly, Inc
Info@cleerlyhealth.com. Patents. Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class …See details»
Leadership | Cleerly, Inc
Cleerly leadership team. Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class technology.See details»
Cleerly - LinkedIn
Cleerly is the company on a mission to eliminate heart attacks by creating a new standard of care for the diagnosis of heart disease. Through its AI-empowered solutions, Cleerly supports ...See details»
Cleerlyhealth - Company Profile
Cleerlyhealth. Cleerly is the company on a mission to eliminate heart attacks by creating a new standard of care for the diagnosis of heart disease. Through its AI-empowered solutions, …See details»
Cleerly - Crunchbase Company Profile & Funding
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary …See details»
Cleerly Company Profile | Management and Employees List
Cleerly Profile and History. Founded in 2016, Cleerly is the company creating a new standard of care for heart disease. Through value-based precision diagnostic solutions driven by machine …See details»
Cleerly, Inc - aidirectory.org
Email : info@cleerlyhealth.com. Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care …See details»
Cleerly - Overview, News & Similar companies | ZoomInfo.com
Jun 2, 2024 Who is Cleerly. Cleerly is the company creating a new standard of care for heart disease. Through value-based precision diagnostic solutions driven by machine inte lligence, …See details»
Newsroom: Cleerly Expands Executive Team
Sep 29, 2021 In that position, he built the myStrength platform and technology organization from the ground up leading to the acquisition of the company by Livongo in 2019. At Cleerly, Nieslanik will drive Cleerly’s technical and product …See details»
Cleerly - LRVHealth
Www.cleerlyhealth.com. About Cleerly. Cleerly is creating a new standard of care for heart disease. Through its FDA-cleared, value-based diagnostic solutions driven by artificial and …See details»
Working At Cleerly: Company Overview and Culture - Zippia
Mar 14, 2024 cleerlyhealth.com. Organization Type. Private. CEO. James K. Min. Social Media. Cleerly aims to revolutionize the classroom experience by allowing students and professors to …See details»
Cleerly Company Profile | Management and Employees List
SQL International Organization for Standardization . Python Python Software Foundation . HTML Web Hypertext Application Technology Working Group . ... Smith@cleerlyhealth.com: Cleerly …See details»
Bunkerhill Health and Cleerly Announce Strategic Partnership to …
Mar 4, 2025 For more information, visit bunkerhillhealth.com and cleerlyhealth.com. About Bunkerhill Bunkerhill Health is a pioneering healthcare technology company dedicated to …See details»
Cleerly Named to NYC Digital Health 100 by New York City Health ...
Feb 2, 2022 Organization recognizes the most promising and innovative health startups in New York. February 02, 2022 10:36 AM Eastern Standard Time ... For more information, please …See details»
Cleerly Expands Board of Directors with Three New Members
NEW YORK – November 09, 2021 --Cleerly, the company creating a new standard of care for heart disease, announced today it has expanded its board of directors with three new medical …See details»
News | Cleerly, Inc
Nov 9, 2021 February 2, 2022. Cleerly Named to NYC Digital Health 100 by New York City Health Business Leaders. New York City Health Business Leaders (NYCHBL), the …See details»
Bunkerhill Health and Cleerly Announce Strategic Partnership to …
Mar 4, 2025 SAN FRANCISCO & DENVER, March 04, 2025--Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, …See details»
Has anyone had the Cleerly test? | Mayo Clinic Connect
Jun 25, 2023 Their is some gray zones around it, but I think it has some value---just my humble opinion, nothing more. The insurances that do cover it, generally require a stenosis of at lest …See details»
Cleerly COMPARE - cleerlyhealth.com
Why Cleerly COMPARE. Cleerly COMPARE is a revolutionary feature that empowers physicians to evaluate changes to coronary artery disease (CAD) and helps guide therapeutic decisions …See details»